Kristen M. Oelschlager - 01 Sep 2026 Form 4 Insider Report for CASTLE BIOSCIENCES INC (CSTL)

Source evidence Original filing metadata and source links for verification. 4 source fields
SEC form
4
Accepted by SEC
03 Sep 2026, 16:07:34 UTC
Prior SEC filing
26 Aug 2026
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
/s/ Frank Stokes, Attorney-in-fact

Key filing fact

Kristen M. Oelschlager filed Form 4 for CASTLE BIOSCIENCES INC (CSTL) on 03 Sep 2026.

Key facts

  • This page summarizes Kristen M. Oelschlager's Form 4 filing for CASTLE BIOSCIENCES INC (CSTL).
  • 4 reported transactions and 1 derivative row are listed below.
  • Accepted by SEC: 03 Sep 2026, 16:07.

Change

  • Previous filing in this sequence was filed on 26 Aug 2026.
  • Current net transaction value: -$138,643.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001856565 Primary reporting owner

Oelschlager Kristen M

Relationship
Chief Operating Officer
Address
C/O CASTLE BIOSCIENCES, INC., 1500 W. PARKWOOD AVE SUITE 400, FRIENDSWOOD
Signature
/s/ Frank Stokes, Attorney-in-fact
Signature date
03 Sep 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

CSTL transaction

Common Stock

Options Exercise

Transaction value
Shares
+4,152
Change %
+31%
Price
$3.38*
Shares after
17,508
Date
01 Sep 2026
Ownership
Direct
Footnotes
F1, F2
CSTL transaction

Common Stock

Sale

Transaction value
$131,839
Shares
-3,952
Change %
-23%
Price
$33.36
Shares after
13,556
Date
01 Sep 2026
Ownership
Direct
Footnotes
F1, F3
CSTL transaction

Common Stock

Sale

Transaction value
$6,804
Shares
-200
Change %
-1.5%
Price
$34.02
Shares after
13,356
Date
01 Sep 2026
Ownership
Direct
Footnotes
F1
CSTL holding

Common Stock

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
72,649
Date
01 Sep 2026
Ownership
The Fritz Shorter Trust
Footnotes
F4

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

CSTL transaction Derivative

Stock option (right to buy)

Options Exercise

Transaction value
Shares
-4,152
Change %
-25%
Price
$0.000000*
Shares after
12,458
Date
01 Sep 2026
Ownership
Direct
Underlying class
Common Stock
Underlying amount
4,152
Exercise price
$3.38
Footnotes
F1, F5
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Rule 10b5-1 trading plan

These transactions were reported as open-market trades under a Rule 10b5-1 plan. The plan lets an insider set trading instructions in advance, which can reduce the risk of trading while in possession of material nonpublic information.

Original filing language: transaction made pursuant to a contract, instruction, or written plan intended to satisfy Rule 10b5-1(c).

Explanation of responses 5 footnotes

Footnote F1

These transactions were made pursuant to a Rule 10b5-1 plan adopted by the Reporting Person, on March 17, 2026.

Footnote F2

Includes 68 shares acquired on August 31, 2026, under the Issuer's employee stock purchase plan.

Footnote F3

This transaction was executed in multiple trades at prices ranging from $33.015 to $33.900, inclusive. The price reported above reflects the weighted-average sale price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

Footnote F4

Held by the Fritz Shorter Trust of which the Reporting Person and her spouse are the trustees and beneficiaries.

Footnote F5

The shares subject to the option are fully vested.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .